About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Cardiovascular Disease Risk Prevention Across Europe

Citation:

European Cardiovascular Disease 2007;3(2):14–9

Clinical Benefits of Inhibition of Cholesterol Absorption for Japanese Patients with Dyslipidaemia

Citation:

Asia-Pacific Cardiology 2007;1(1):11-3

Developments in Magnetic Resonance Imaging of Atherosclerosis

Citation:

US Cardiology 2007;4(1):63–5

Interventional Cardiology for Coronary Artery Disease

Citation:

European Cardiovascular Disease 2006;2(1):1–3